# High Tide to Present at Several Major International Cannabis and Investor Conferences > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/corporate-cannabis-conference-presentations/ > **Published:** 2026-04-13T07:18:21-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T14:01:36-04:00 > **Clinical Summary:** Explore corporate cannabis conference presentations and their impact on industry and investor relations in the cannabis market. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic IndustryBusinessInvestmentCannabis Market Why This Matters Corporate cannabis conference presentations reflect industry maturation and investor interest, but have limited direct clinical relevance. These events primarily serve commercial stakeholders rather than advancing [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) or clinical evidence. Clinical Summary High Tide, a cannabis retail company, announced participation in multiple investor and industry conferences. This represents typical corporate communications for publicly traded cannabis companies seeking to maintain market visibility. No clinical data, patient outcomes, or therapeutic developments were mentioned in this announcement. Dr. Caplan’s Take “Corporate conference circuits are about business development, not medicine. Clinicians should focus on peer-reviewed research and clinical evidence rather than investor presentations when making [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions.” Clinical Perspective 🧠 This type of business announcement does not inform clinical practice or patient care decisions. Healthcare providers should continue to rely on published [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/), safety data, and established medical guidelines when considering [cannabis therapeutics](https://cedclinic.com/firearms-regulatory-guidance-cannabis/) for patients. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20High%20Tide%20to%20Present%20at%20Several%20Major%20International%20Cannabis%20and%20Investor%20Confer...%20%40drcaplan&url=https%3A//ca.finance.yahoo.com/news/high-tide-present-several-major-100000466.html)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//ca.finance.yahoo.com/news/high-tide-present-several-major-100000466.html)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20High%20Tide%20to%20Present%20at%20Several%20Major%20International%20Cannabis%20and%20Investor%20Confer...%20--%20via%20%40drcaplan.bsky.social%20https%3A//ca.finance.yahoo.com/news/high-tide-present-several-major-100000466.html)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://ca.finance.yahoo.com/news/high-tide-present-several-major-100000466.html](https://ca.finance.yahoo.com/news/high-tide-present-several-major-100000466.html) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What categories does this cannabis news cover?](#What_categories_does_this_cannabis_news_cover) - [Why is this cannabis news marked as “New”?](#Why_is_this_cannabis_news_marked_as_8220New8221) - [What should healthcare professionals know about this cannabis update?](#What_should_healthcare_professionals_know_about_this_cannabis_update) - [How significant are these cannabis market developments?](#How_significant_are_these_cannabis_market_developments) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests emerging findings or policy developments in the [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) that are worth monitoring closely by healthcare professionals. #### What categories does this cannabis news cover? The article covers multiple aspects of the cannabis sector including Industry developments, Business operations, Investment opportunities, and broader Cannabis Market trends. This comprehensive coverage indicates significant developments affecting multiple stakeholders in the cannabis space. #### Why is this cannabis news marked as “New”? The “New” designation indicates this is recently published information about developments in the [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/). This suggests timely and current information that may impact clinical practice, business decisions, or market dynamics. #### What should healthcare professionals know about this cannabis update? Healthcare professionals should be aware that this represents emerging developments in the cannabis industry that may have clinical implications. The “Notable Clinical Interest” rating suggests these developments could influence treatment options, [patient access](https://cedclinic.com/iowa-medical-cannabis-dispensaries-expansion/), or regulatory considerations. #### How significant are these cannabis market developments? The combination of industry, business, investment, and market tags suggests these are comprehensive developments affecting multiple sectors of the cannabis industry. The clinical relevance rating indicates these changes are substantial enough to warrant attention from medical professionals and industry stakeholders. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence Financial Research Associate Salaries in the United States for Cannabis Employment Professionals Explore salary trends for financial research associates in the cannabis sector, providing insights into employment opportunities and market growth. Learn More Central Bancompany, Inc. Announces Conference Call to Discuss First Quarter 2026 Results Stay updated on Central Bancompany's financial results and strategic outlook impacting the cannabis investment landscape. Read Update [Free cash flow per share of Cannabis Strategic Ventures – OTC:NUGS – TradingView](https://cedclinic.com/cannabis-company-financial-metrics-free-cash-flow/) Analyze the financial health and cash flow metrics of Cannabis Strategic Ventures to inform investment decisions. [View Analysis](https://cedclinic.com/cannabis-company-financial-metrics-free-cash-flow/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).